Last reviewed · How we verify

Levobupivacaine epidural bolus

University of Genova · FDA-approved active Small molecule

Levobupivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of action potentials.

Levobupivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses. Used for Epidural anesthesia for surgical procedures, Epidural analgesia for postoperative pain management.

At a glance

Generic nameLevobupivacaine epidural bolus
SponsorUniversity of Genova
Drug classLocal anesthetic (amino amide)
TargetVoltage-gated sodium channels
ModalitySmall molecule
Therapeutic areaAnesthesia
PhaseFDA-approved

Mechanism of action

Levobupivacaine is the S-enantiomer of bupivacaine, a long-acting amide local anesthetic. When administered epidurally, it diffuses across the dura mater to block voltage-gated sodium channels on nerve fibers, preventing depolarization and transmission of pain signals. The S-enantiomer formulation offers improved cardiac safety compared to the racemic mixture.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results